chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approx at 11:10 PM, after Pfizer vaccine dose 1 was administered by vaccine lead, pt stated her throat felt itchy. At that time, pt had no difficulty talking or drinking water. Denied chest pain, general itchiness, difficulty breathing, and no swelling of the tongue/lips was observed. BP 125/81, O2 100%, P 80, R 18, a/o x4.  RN was notified immediately and care was transferred and benadryl was given by RN.
11/21/16 early evening with soreness in arm and limited use. Developed chills & fever later that evening. Tuesday 11/22/16 - Early morning - felt better - no chills - felt very tired and slept most of the day Early evening - fever (101) returned with chills - slept most of the night. Wednesday 11/23/16 Fever and chills gone. Redness on arm.
Information has been received from a physician concerning an approximately 16 year old female with no known drug allergies and no medical history reported, who on an unknown date was vaccinated with the second dose of GARDASIL vaccine (yeast). There was no concomitant medication. On an unspecified date, 2 weeks after vaccination, the patient experienced syncope. The patient was also exercising at the time of adverse event. The patient recovered from syncope. The patient sought medical attention at the office. No further information is available.
Shortly after receiving IM injection, began to c/o "itching" around lips. BENADRYL given, also c/o legs cramping and nausea. Mom ended up taking him to MD office next day.
Client reported she self-medicated with Motrin and symptoms resolved the next day (2 days after vaccination). Client denied having any allergies or chronic conditions and she did not follow-up with a physician regarding side-effects. Vaccine site lead provided education to client and mother on COVID-19 vaccine side-effects and encouraged to report any additional side-effects on VSAFE. Clinical coordinator was consulted and provided approval to administer 2nd dose with a 30-minute observation period.
pruritus began 10 days after booster, hives started to appear and spread after scratching area. Heartburn also began to develop. Went to urgent care, was prescribed medrol pack as well as topical steroids cream and histamine medication. Currently on day 3 of medrol pack with improvement noted.
Pt recv vax on 3/18/98; on 3/19/98 pt exp numb lips w/ drooping one side & burning eyes; dx=Bell's Palsy of viral etiology.  Pt tx=Prednisone
Vaccine administration error. A large amount of liquid spilled down my arm when the technician pulled the syringe out. I am certain that I did not receive a proper dose. I tried to mention it to the technician but she just wiped up the liquid and ushered me out. I later noted it to the pharmacist on duty.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 22-MAY-2012, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 26-MAY-2016, a few days after being vaccinated with ZOSTAVAX (conflicting information: it was also reported that the pt. was vaccinated in 2012) the patient was treated by a physician for a vesicular rash, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Information has been received from a consumer concerning her 28 year old female niece with no pertinent medical history and no drug reactions or allergies who in May 2008 was vaccinated with the first dose of GARDASIL. The patient had no adverse experience after first vaccination. On an unspecified date, the patient was vaccinated with the second dose of GARDASIL. There was no concomitant medication. Subsequently, within a week after the patient received the second dose of GARDASIL, the patient experienced tunnel vision, migraine headaches, shortness of breath, paralyzation. The patient couldn't move her right arm. Her right leg was now getting stiffed. The patient had seizure after two weeks of receiving the second dose of GARDASIL and she had been having seizures periodically since then. The patient was hospitalized twice (Hospital demographics and number of days of hospitalization were unspecified), once in 2008 and another in 2009. The patient was currently at home and she was bedridden. Therapy with GARDASIL was discontinued. At the time of the report, the patient had not recovered. Additional information has been requested.  12/29/2009 PCP records for 6/2008 to 11/2009. Patient with c/o's rt arm paresis, seizure activity, dizziness, syncope, headaches, ? etiology, has had multiple ED visits for these c/o's, unable to work since 4/2008, lack of insurance has prevented appropriate consults and further testing
Patient got a abnormal EKG a few months after the covid shot in November, 2021, then got  congestive  heart failure and died 12-22-22
Itchy and prickly/she had a mild sense of itchiness; Itchy and prickly/she had a mild sense of itchiness; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (age: 83; unit: unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported, Expiration Date was not provided) dose 1, via an unspecified route of administration on 04Feb2021 as single dose for covid-19 immunization. Medical history included Allergic to the elements like greens from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient wanted to know if itchiness was a normal side effect of the PFIZER-BIONTECH COVID-19 VACCINE - Got the 1st dose 04Feb2021 and 10 hours after she felt like itchy and prickly (04Feb2021). She stated had the first dose 24 hours ago. About 10 hours in, she had a mild sense of itchiness, which was dissipating now. She has had that itchiness when she goes outdoors. She was Allergic to the elements like greens, etc. She got that when she goes outdoors. She would like to find out if this was a side effect. The outcome of event was unknown.  Follow-up (19Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
I have an excruciating pain in mi right arm; SOMETIMES I CANNOT MOVE MI ARM I TRY & LIFT IT UP ITS SUPER HEAVY; SOMETIMES I CANNOT MOVE MI ARM I TRY &LIFT IT UP ITS SUPER HEAVY THAN ITS A SHOOTING PAIN FROM MI NECK TO MI CHEST BUT MOSTLY THE ARM; SOMETIMES I CANNOT MOVE MI ARM I TRY &LIFT IT UP ITS SUPER HEAVY THAN ITS A SHOOTING PAIN FROM MI NECK TO MI CHEST BUT MOSTLY THE ARM; Second dose of BNT162B2 was administered  after 42 days of first dose; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 18Jun2021 at 15:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported as none. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 18Apr2021 at 15:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. On 05Aug2021 at 00:00, the patient had an excruciating pain in her right arm and sometimes she could not move her arm. When the patient tried to lift it up, it was super heavy than it was a shooting pain from her neck to her chest but mostly the arm. Therapeutic measures were not taken as a result of the reported events. The adverse events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events excruciating pain in right arm, sometimes could not move arm, tried and lifted it up it was super heavy than its a shooting pain from neck to chest but mostly the arm was not resolved at the time of this report.     The lot number for BNT162b2 was not provided and will be requested during follow up.
About 5 minutes after receiving the injection I had a headache, my ears got hot, i felt nauseous and my eyes turned red. Today my arm is swollen and painful.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 24-SEP-2013 the patient was vaccinated with PNEUMOVAX23 (lot # 0217AE; expiry date: 22-AUG-2013). No adverse effect. The outcome of event was unknown. Additional information has been requested.
Guillain-Barre Syndrome- prosimal upper limb malgias, followed by progressive 4-limb (prox>distal) weakness, hand paresthesias, bifacial weakness, areflexia, over 4-5 days.  Course complicated by SIADH and hyponatremia.  Currently treating with plasmapheresis.
A report had been received from a health Professional concerning a 15 years old male patient. No information regarding relevant medical history, concomitant disease or concomitant medication was provided. The patient had received nasal FLUMIST QUADRIVALENT started during Oct-2013. It was reported that a total of four of their patients received FLUMIST and later tested positive for the flu which started on 15-Dec-2013. Action taken with FLUMIST QUADRIVALENT was unknown. The outcome of the event of tested positive for flu was unknown. The reporter assessed the event of tested positive for flu to be non-serious.
pt recv vax 20JUL95 & APR97 3wk a/onset of sx pt was exposed to chickenpox;28APR97 pt devel an itchy rash consisting of @ least 25 lesions over scalp, chest, abd, thighs & back that looked like chickenpox;
Information was received on 19-APR-2017 from a lawyer regarding a case in litigation concerning a female patient of unknown age. It is alleged that the patient was inoculated with a dose of ZOSTAVAX vaccine on or about 07-AUG-2012 at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 22-JUL-2016, the patient was treated at a medical center for a painful rash that was diagnosed as shingles. While shingles is an incurable condition, the patient was prescribed acyclovir to manage her symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering and other damages. Additional information has been requested.
I started developing diarrhea a week after the vaccination. Duration of 3 days, 1 day of break and then started again. I have been taking IMODIUM from the beginning and electrolytes. Diarrhea continues consistently.
TINGLING IN FACE AND ARMS, PERIORBITAL EDEMA, NEXT DAY FACIAL SWELLING, COUGH, VOMITING, DIARRHEA, CHILLS, LIPS FELT SWOLLEN
This case was reported by a nurse via call center representative and described the occurrence of headache in a 62-year-old female patient who received SHINGRIX (batch number B5EK2, expiry date 28th April 2020). Concomitant products included VALTREX. On 23rd March 2018 08:28, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In March 2018, less than a week after receiving SHINGRIX, the patient experienced headache, fatigue, erythema of extremities and skin warm. On an unknown date, the outcome of the headache, fatigue, erythema of extremities and skin warm were not recovered/not resolved. The reporter considered the headache, fatigue, erythema of extremities and skin warm to be almost certainly related to SHINGRIX. Additional information was received were as follows: The patient reportedly was prescribed with the course of VALTREX in February. No details were provided regarding diagnosis or exact duration. But the therapy was completed prior to the administration of SHINGRIX. No concomitant vaccines were administered. The patient received the SHINGRIX on the right arm. The health care professional reported that the patient returned to the clinic on 26th March 2018. The patient reported experiencing headache and fatigue over the weekend and she presented with the "whole upper part" of her arm red and warm to the touch. The patient was referred to her physician for further evaluation. The health care professional was unable to provide a more definite information regarding start of reaction.
Rash x1 day, warm to touch, nontender, no itching - monitor
pt complaint of lightheaded/dizziness pt felt like "passing out" pt had perspiration on brown as well as loss of color in skin. pt was brought to observation area wher vitals were taken. pt claimed "for a moment if felt like i couldn't breath." pt was coached to breath and try to relax. pt bp 105/51 hr 61 spo2 96% rr 18. pt, after a few minutes "felt much better". pt was was released once feeling better. pt like experienced vasal vagal response. pt had denied any chest tightness or swelling in throat or mouth. pt was able to ambulate with escort out of facility.
Information has been received from a nurse concerning a 22 year old female who was vaccinated with her first dose of Gardasil.  Subsequently the patient developed little bumps all over her body for a few days after the vaccination.  The outcome was not reported.  Additional information is not expected.
Body aches; chills; SOB; fatigue; This is a spontaneous report from a contactable other healthcare professional (patient). A 20-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number and expiration date were not reported), via an unspecified route of administration in left arm on 22Jan2021 17:00 (reported as 05:00 PM) at SINGLE DOSE for COVID-19 immunisation. The patient was administered COVID-19 vaccine at the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant at the time of vaccination. Medical history included endometriosis, interstitial cystitis, depression, anxiety, post-traumatic stress disorder (PTSD), pelvic pain, migraines, and diagnosis of COVID-19 prior to vaccination. Concomitant medications included etonogestrel (NEXPLANON), duloxetine hydrochloride (CYMBALTA), buspirone hydrochloride (BUSPAR), pantoprazole, and others (unspecified). The patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number and expiration date were not reported) on 31Dec2020 at 11:45 AM at the right arm for COVID-19 immunization and patient was 20-year-old at the time of the vaccination. On 22Jan2021 at 20:30 (reported as 08:30 PM), the patient experienced body aches, chills, shortness of breath (SOB), and fatigue. The reporter considered the events as non-serious. There was no treatment received for the events. It was also reported that since the vaccination, the patient has not been tested for COVID-19. The patient was recovering from the events body aches, chills, SOB, and fatigue.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from a registered nurse, and refers to an unspecified number of patients of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On unspecified dates, the patients were vaccinated with improperly stored doses of VARIVAX, lot # M000757, expiration date 06-JAN-2018, and/or lot # M003440, expiration date 20-JAN-2018 (dose, dose number, route and anatomical location were unspecified). The reporter stated that the vaccines were exposed to 5.5F during 10 minutes. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
PATIENT RECEIVED AN EXPIRED DOSE OF THE JANSSEN COVID-19 VACCINE ON 10/27/21.  PHARMACY NOTIFIED OF MISTAKE ON 3/6/2022.  ATTEMPTED TO CONTACT PATIENT TO REVACCINATE, BUT PATIENT HAS NOT RETURNED CALL.
patient experienced a syncope episode for 60 seconds; patient experienced a syncope episode for 60 seconds; vasodilation; Information has received from a nurse via a field representative, referring to a 9 years old female patient. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not provided.  On 23-OCT-2019, the patient was given the first hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) dose of the series (lot number 1614898, expiration date was not reported defaulted as 15-NOV-2021; frequency, anatomical location and route of administration were unknown) for prophylaxis.  On the same date, the patient experienced a syncope episode for 60 seconds, then recovered. The patient was kept for 30 minutes in the office after the event for observation. The patient's mom reported her daughter had vasodilation and other syncopal episodes after this event due to injuries.  The outcome of vasodilation and syncope episodes occurred later was reported as ongoing. The causality assessment was not provided.  Upon internal review, the event syncope episodes was determined to be medically significant.
I received shot Thursday morning and Friday night or early Saturday morning while sleeping I began having extreme pain and woke up to massive swelling under arm. Later that morning around 9:03-10am I began feelings little numbness in left side of my face. My neck also felt stiff past couple days and Saturday morning felt and looked a little swollen on the left side.
started feeling COVID symptoms on 04May 2021, and received a COVID positive diagnosis on 07May 2021; This is a spontaneous report from a contactable consumer (patient). A 46-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 30Apr2021 08:15 (Batch/Lot Number: EN6207) as single dose for COVID-19 immunisation. Patients Medical History (including any illness at time of vaccination) was none. No Family Medical History Relevant to AE(s). There were no concomitant medications. No history of previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available). No prior vaccinations (within 4 weeks). No AE(s) following prior vaccinations. It was reported that the patient had the first vaccine on 30Apr2021, and started feeling COVID symptoms on 04May 2021, and received a COVID positive diagnosis on 07May 2021. The patient is scheduled on 21May2021 for her second shot, and was trying to decide if should delay her vaccine based on fact that she had COVID after the first shot. States she thinks she is mostly recovered, so she is improving. The patient did a virtual visit to physician office to get scheduled for COVID test, did drive through test. Outcome of the event was recovering.  No follow-up attempts are needed. No further information is expected.
Flu-like symptoms start evening of injection: Fever, Body Aches, Bronchial issues
Patient received a seasonal and H1N1 influenza vaccine in different arms at the same time. She came back to the clinic site 1 hour after the injections complaining of weakness, lightheadedness, nause, dizziness, racing pulse, and shakiness. BP 160/100 P 100. Complained of feeling "awful". She had no difficulty breathing. Since she was a hospital employee, the nurse called the employee health clinic and was advised to take patient to the Emergency Dept. She was brought to the ED around 1 pm. In the ED, she began to complain of scratchiness in her throat, and a rash became visible on her upper chest. Per patient report, the ED provider assessed her as having a vaso-vagal reaction. An IV was begun. She had an EKG, CBC w/ dif, and Chemisty panel done. Oxygen sat and cardiac monitoring was done. Patient reports she was given Ativan to slow her racing pulse. She was discharged approx 4 hours later. The following day she felt back to normal.
L deltoid area swelling, + redness, warm, c/o pain at injection site.  Observe + warm compress.  RTC in 1 wk.
Vaccine administered 12/21/2021 at 2:45 pm, the next morning on 12/22/2021 my son rose from his bed, made it to the hall way, legs buckled and fell straight back.  Was non verbal for @ 1 minute and complained he could not see as well after sitting up.  After the incident he vomited in the bathroom.  Ambulance came and check vitals and blood sugar, all appeared normal.  Called primary care physician to apprise of the incident.
The initial dose of Phizer Covid vaccine exacerbated a preexisting condition. It caused significant hearing loss and made mild tinnitus very severe. Currently being treated with Rozerum sleeping aid and was just prescribed lidocaine patches
Approx 2 weeks after my second Moderna shot, I woke up with severe pain in my left knee, unable to walk.  X-rays were done and the Orthopedic surgeon said I have 60% osteoarthritis in knee and bone on bone.  I had NO prior indications of any type of issue with my knee.  Not even any pain or aches until that morning.  A knee with 60% bone on bone arthritis surely should have given me warning signs prior.  But it didn't.  I am currently awaiting medical clearance for a complete knee replacement.  Hopefully this will happen in July 2021.
2 hours following injection, the patient had onset of chest pain.  Chest pain persisted with worsening over the next 48 hours prompting visit to Hospital emergency department.  Patient had negative troponin but elevated D-Dimer (974) and elevated CRP (43.3).   Echocardiogram as normal.  EKG was unremarkable.  Chest pain has persisted with spread across the chest wall since that time.  She has also developed dyspnea on exertion, starting the day after vaccination.  The dyspnea on exertion has increased in severity and is now limiting with minimal exertion.
Patient received COVID-19 vaccine. After approximately ten minutes of sitting in the waiting area, patient began feeling ill. As he was walking up to the drop-off window to tell staff how he was feeling, he fainted and hit the back of his head on the ground. Patient was unresponsive so 911 was called. Patient was extremely pale, hot, and clammy, but slowly started to regain responsiveness. Patient reported blacking out. While waiting for paramedics, two cold ice packs were applied to the patient's head and neck. Paramedics arrived and assessed the patient. They released him from their care as free to go. Patient sat down outside the pharmacy for approximately ten more minutes. Once he decided he was feeling better, he walked around outside the pharmacy until he felt okay to leave. Prior to leaving, patient reported he was feeling better and appeared to be in good spirits. He also reported having fasting labs drawn 45 minutes prior to receiving the vaccine, as well as low blood pressure at his doctor's office. He confirmed ability to drive. Patient left the pharmacy approximately 45 minutes after receiving the vaccine.